-
1Academic Journal
المؤلفون: Oliveira, M, Falato, C, Cejalvo, JM, Vila, MM, Tolosa, P, Salvador-Bo, FJ, Cruz, J, Arumi, M, Luna, AM, Guerra, JA, Vidal, M, Martinez-Saez, O, Pare, L, Gonzalez-Farre, B, Sanfeliu, E, Ciruelos, E, Espinosa-Bravo, M, Pernas, S, Izarzugaza, Y, Esker, S, Fan, PD, Parul, P, Santhanagopal, A, Sellami, D, Villacampa, G, Ferrero-Cafiero, JM, Pascual, T, Prat, A
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 34(8):670-680
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2Academic Journal
المؤلفون: Yu, H.A., Baik, C., Kim, D.-W., Johnson, M.L., Hayashi, H., Nishio, M., Yang, J.C.-H., Su, W.-C., Gold, K.A., Koczywas, M., Smit, E.F., Steuer, C.E., Felip, E., Murakami, H., Kim, S.-W., Su, X., Sato, S., Fan, P.-D., Fujimura, M., Tanaka, Y., Patel, P., Sternberg, D.W., Sellami, D., Janne, P.A.
المساهمون: Kim, D.-W.
مصطلحات موضوعية: TYROSINE KINASE INHIBITORS, ANTIBODY-DRUG CONJUGATE, CELL LUNG-CANCER, RESISTANCE, DS-8201A, EFFICACY
Relation: Annals of Oncology, Vol.35 No.5, pp.437-447; https://hdl.handle.net/10371/204596; 001239681400001; 2-s2.0-85190305997; 216083
-
3Academic Journal
المؤلفون: Yu, HA, Goto, Y, Hayashi, H, Felip, E, Chih-Hsin Yang, J, Reck, M, Yoh, K, Lee, S-H, Paz-Ares, L, Besse, B, Bironzo, P, Kim, D-W, Johnson, ML, Wu, Y-L, John, T, Kao, S, Kozuki, T, Massarelli, E, Patel, J, Smit, E, Reckamp, KL, Dong, Q, Shrestha, P, Fan, P-D, Patel, P, Sporchia, A, Sternberg, DW, Sellami, D, Jaenne, PA
Relation: Yu, H. A., Goto, Y., Hayashi, H., Felip, E., Chih-Hsin Yang, J., Reck, M., Yoh, K., Lee, S. -H., Paz-Ares, L., Besse, B., Bironzo, P., Kim, D. -W., Johnson, M. L., Wu, Y. -L., John, T., Kao, S., Kozuki, T., Massarelli, E., Patel, J. ,. Jaenne, P. A. (2023). HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy. Journal of Clinical Oncology, 41 (35), pp.5363-5378. https://doi.org/10.1200/JCO.23.01476.; http://hdl.handle.net/11343/337233
الاتاحة: http://hdl.handle.net/11343/337233
-
4Academic Journal
المؤلفون: Pistilli, B., Ibrahimi, N., Lacroix-Triki, M., D'Hondt, V., Vicier, C., Frenel, J-S., Dalenc, F., Bachelot, T., Benderra, M-A., Loirat, D., Ducoulombier, A., Mayeur, D., Nachabeh, G.B., Serhal, K., Corcos, N., Sellami, D., Michiels, S., André, F., Mosele, M.F., Montagnac, G.
المصدر: ESMO Open ; volume 8, issue 1, page 101378 ; ISSN 2059-7029
-
5Academic Journal
المؤلفون: Hamilton, E.P., Bagegni, N.A., Beck, J.T., Cultrera, J.L., Dosunmu, O., Gwin, W.R., Heeke, A.L., Khoury, K., Sellami, D., Shastry, M., Sternberg, D.W., Toppmeyer, D., Wright-Browne, V.M., Yuan, Y.
المصدر: Annals of Oncology ; volume 33, page S220 ; ISSN 0923-7534
-
6Academic Journal
المؤلفون: Peveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z.
المصدر: EUROPEAN JOURNAL OF CANCER
Relation: https://doi.org/10.1016/S0959-8049(11)71871-8; https://openrepository.ru/article?id=259564
-
7Academic Journal
المؤلفون: Peveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z.
المصدر: Clinical Therapeutics
مصطلحات موضوعية: Healthy subjects, Hepatic impairment, Molecular therapeutics, Pharmacokinetics
-
8Academic Journal
المؤلفون: Yu, H.A., Goto, Y., Hayashi, H., Felip, E., Yang, J.C.-H., Reck, M., Yoh, K., Lee, S.-H., Paz-Ares, L., Besse, B., Bironzo, P., Kim, D.-W., Johnson, M.L., Wu, Y.-L., Vigliotti, M., Dong, Q., Fan, P.-D., Shrestha, P., Sternberg, D.W., Sellami, D., Jänne, P.A.
المصدر: Journal of Thoracic Oncology ; volume 18, issue 11, page S53-S54 ; ISSN 1556-0864
-
9Academic Journal
المؤلفون: Lear, J.T., Migden, M.R., Lewis, K.D., Chang, A.L.S., Guminski, A., Gutzmer, R., Dirix, L., Combemale, P., Stratigos, A., Plummer, R., Castro, H., Yi, T., Mone, M., Zhou, J., Trefzer, U., Kaatz, M., Loquai, C., Kudchadkar, R., Sellami, D., Dummer, R.
المساهمون: Novartis Pharmaceuticals Corporation
المصدر: Journal of the European Academy of Dermatology and Venereology ; volume 32, issue 3, page 372-381 ; ISSN 0926-9959 1468-3083
-
10Academic Journal
المؤلفون: Sellami, D., Dharan, B., Wilke, C., Scherer, S.J., Hirawat, S.
المساهمون: Novartis Pharmaceuticals Corporation
المصدر: Annals of Oncology ; volume 28, issue 11, page 2882-2887 ; ISSN 0923-7534
-
11Academic JournalA Matching Adjusted Indirect Comparison Of Sonidegib And Vismodegib In Advanced Basal Cell Carcinoma
المؤلفون: Odom, D, Mladsi, DM, Purser, M, Kaye, JA, Palaka, E, Charter, A, Jensen, JA, Sellami, D
المصدر: Value in Health ; volume 19, issue 3, page A122 ; ISSN 1098-3015
-
12Academic Journal
المؤلفون: Guminski, A, Stull, D, Houghton, K, Gutzmer, R, Migden, MR, Dirix, L, Lewis, KD, Combemale, P, Herd, RM, Kudchadkar, R, Trefzer, U, Sellami, D, Lear, J, Dummer, R
المصدر: Value in Health ; volume 19, issue 3, page A159 ; ISSN 1098-3015
-
13Academic Journal
المؤلفون: Aouadj, M., Naceri, F., Touileb, M., Sellami, D., Boukhatem, M.
المصدر: Research Journal of Applied Sciences, Engineering and Technology ; volume 10, issue 7, page 789-804 ; ISSN 2040-7459 2040-7467
-
14Academic Journal
المؤلفون: Dummer, R., Guminski, A., Gutzmer, R., Dirix, L., Lewis, K., Combemale, P., Herd, R., Kaatz, M., Loquai, C., Stratigos, A., Schulze, H., Plummer, R., Yi, T., Chang, A.L.S., Cornélis, F., Kudchadkar, R., Trefzer, U., Lear, J., Sellami, D., Migden, M.R.
المصدر: Annals of Oncology ; volume 25, page v1 ; ISSN 0923-7534
الاتاحة: http://dx.doi.org/10.1093/annonc/mdu438.41
https://api.elsevier.com/content/article/PII:S0923753419531039?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419531039?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/25/suppl_4/mdu438.41/9692465/mdu438.41.pdf -
15Academic Journal
المؤلفون: Dummer, R., Gutzmer, R., Migden, M.R., Dirix, L., Lewis, K., Combemale, P., Higuchi, K., Gogov, S., Yi, T., Herd, R., Kudchadkar, R., Trefzer, U., Lear, J., Sellami, D., Guminski, A.
المصدر: Annals of Oncology ; volume 25, page iv390 ; ISSN 0923-7534
-
16Academic Journal
المؤلفون: Campone M., Im S. -A., Iwata H., Clemons M., Ito Y., Awada A., Chia S., Jagiello-Gruszfeld A., Pistilli B., Tseng L. -M., Hurvitz S., Masuda N., Cortes J., De Laurentiis M., Arteaga C. L., Jiang Z., Jonat W., Le Mouhaer S., Sankaran B., Bourdeau L., El-Hashimy M., Sellami D., Baselga J.
المساهمون: Campone, M., Im, S. -A., Iwata, H., Clemons, M., Ito, Y., Awada, A., Chia, S., Jagiello-Gruszfeld, A., Pistilli, B., Tseng, L. -M., Hurvitz, S., Masuda, N., Cortes, J., De Laurentiis, M., Arteaga, C. L., Jiang, Z., Jonat, W., Le Mouhaer, S., Sankaran, B., Bourdeau, L., El-Hashimy, M., Sellami, D., Baselga, J.
مصطلحات موضوعية: Buparlisib, ctDNA, Fulvestrant, Hormone receptor-positive breast cancer, Overall survival, PIK3CA, Aminopyridine, Antineoplastic Combined Chemotherapy Protocol, Breast Neoplasm, Double-Blind Method, Female, Human, Middle Aged, Morpholine, Postmenopause, Survival Analysis
Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000447292100018; volume:103; firstpage:147; lastpage:154; numberofpages:8; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11588/804134; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85053465768
-
17Academic Journal
المؤلفون: Ammar-Keskes, L., Gdoura, R., Bouzid, F., Salah, F. Ben, Sellami, D., Hakim, H., Hammami, A., Rebaï, T., Rekik, S., Orfila, J.
المصدر: Andrologie ; volume 8, issue 1, page 25-35 ; ISSN 1166-2654 1760-5377
-
18Academic Journal
المؤلفون: Di Leo, A, Johnston, S, Lee, KS, Ciruelos, E, Lønning, PE, Janni, W, O'Regan, R, Mouret-Reynier, M-A, Kalev, D, Egle, D, Csőszi, T, Bordonaro, R, Decker, T, Tjan-Heijnen, VCG, Blau, S, Schirone, A, Weber, D, El-Hashimy, M, Dharan, B, Sellami, D, Bachelot, T
المساهمون: Johnston, Stephen, Marsden
مصطلحات موضوعية: Humans, Breast Neoplasms, Disease Progression, Aminopyridines, Morpholines, Estradiol, Receptor, erbB-2, Receptors, Estrogen, Progesterone, Antineoplastic Combined Chemotherapy Protocols, Protein Kinase Inhibitors, Disease-Free Survival, Treatment Outcome, Double-Blind Method, Time Factors, Aged, Middle Aged, Female, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases, Estrogen Receptor Antagonists, Biomarkers, Tumor
وصف الملف: Print-Electronic; 100; image/png
Relation: The Lancet. Oncology, 2018, 19 (1), pp. 87 - 100; https://repository.icr.ac.uk/handle/internal/1053
-
19Academic Journal
المؤلفون: Kammoun, S., Frikha, F., Sellami, D., Ben Amor, S., Snoussi, M., Ben Salah, R., Bahloul, Z., Feki, J.
المصدر: La Revue de Médecine Interne ; volume 39, page A211 ; ISSN 0248-8663
-
20